Meloxicam tablets bulk supplier for pharma manufacturers

Meloxicam Tablets 7.5 mg, 15 mg Suppliers & Bulk Manufacturers

Available Forms: Oral Tablets

Available Strengths: 7.5 mg, 15 mg

Reference Brands: Mobic(US & EU)

Category: Analgesic

Meloxicam inhibits cyclooxygenase enzymes (COX-1 and COX-2), reducing prostaglandin synthesis involved in pain and inflammation. Benefits include effective relief from osteoarthritis, rheumatoid arthritis, and chronic inflammatory conditions, with once-daily dosing, a favorable safety profile, and targeted anti-inflammatory effects, improving joint function and quality of life.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Meloxicam tablets are approved in the EU and US for osteoarthritis, rheumatoid arthritis, and juvenile idiopathic arthritis. In the EU, brands like Mobic are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval is based on extensive clinical data; generic options are also available. Both regions require detailed dossiers for initial approval and ongoing pharmacovigilance. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We facilitate efficient market access for meloxicam tablets, ensuring adherence to European and US standards for safe, effective anti-inflammatory treatment, helping you navigate complex regulatory landscapes seamlessly.

Meloxicam Tablets — third party manufacturing & bulk supply

Meloxicam Tablets 7.5 mg, 15 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Meloxicam Tablets is supplied as Oral Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Meloxicam Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Meloxicam Tablets →

Back to Listing

Frequently Asked Questions

Meloxicam is used to relieve pain, inflammation, and swelling in conditions such as osteoarthritis, rheumatoid arthritis, and juvenile idiopathic arthritis.

Meloxicam is made from the active ingredient meloxicam, a non-steroidal anti-inflammatory drug (NSAID), along with standard pharmaceutical excipients depending on the formulation.

Common trade names include Mobic, Meloxicam (branded generics), and Movalis in various regions.

Meloxicam is manufactured by multiple global pharmaceutical companies across the USA, EU, UK, and other approved regions under different brand names.

The generic name is meloxicam.

Well-known brand names include Mobic and Movalis, along with several regional branded generics.

It is manufactured in several countries worldwide, including the USA, Europe, the UK, and other internationally approved pharmaceutical manufacturing locations.